Detalhe da pesquisa
1.
Genetic Epidemiology of Amyotrophic Lateral Sclerosis in Norway: A 2-Year Population-Based Study.
Neuroepidemiology
; 56(4): 271-282, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576897
2.
Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe.
Muscle Nerve
; 55(6): 819-827, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641227
3.
Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations.
Mol Med
; 21(1): 769-781, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26562150
4.
Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries.
Neuroepidemiology
; 44(4): 221-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26068011
5.
Improvement of fatigue in generalised myasthenia gravis with zilucoplan.
J Neurol
; 271(5): 2758-2767, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400914
6.
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Ther Adv Neurol Disord
; 17: 17562864241243186, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638673
7.
Repeat expansions in AR, ATXN1, ATXN2 and HTT in Norwegian patients diagnosed with amyotrophic lateral sclerosis.
Brain Commun
; 6(2): fcae087, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585669
8.
Risk for myasthenia gravis maps to a (151) ProâAla change in TNIP1 and to human leukocyte antigen-B*08.
Ann Neurol
; 72(6): 927-35, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23055271
9.
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Neurol
; 22(5): 395-406, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37059508
10.
Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients.
Muscle Nerve
; 43(4): 574-7, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21305573
11.
Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.
Front Immunol
; 12: 667336, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163474
12.
Serological and experimental studies in different forms of myasthenia gravis.
Ann N Y Acad Sci
; 1413(1): 143-153, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377162
13.
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG.
Neurol Neuroimmunol Neuroinflamm
; 4(4): e357, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28626780
14.
Increased risk for clinical onset of myasthenia gravis during the postpartum period.
Neurology
; 87(20): 2139-2145, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27770065
15.
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis.
Ann Clin Transl Neurol
; 1(5): 329-39, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25356403
16.
Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population.
PLoS One
; 7(5): e36603, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22590574